[
  {
    "ts": null,
    "headline": "AbbVie (ABBV) Outperforms Broader Market: What You Need to Know",
    "summary": "AbbVie (ABBV) reached $187.12 at the closing of the latest trading day, reflecting a +1.23% change compared to its last close.",
    "url": "https://finnhub.io/api/news?id=6cc2cd9e89e693ca900d873296c27aa879980a40a32c683abb179ffdd5976703",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753220705,
      "headline": "AbbVie (ABBV) Outperforms Broader Market: What You Need to Know",
      "id": 136038217,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "AbbVie (ABBV) reached $187.12 at the closing of the latest trading day, reflecting a +1.23% change compared to its last close.",
      "url": "https://finnhub.io/api/news?id=6cc2cd9e89e693ca900d873296c27aa879980a40a32c683abb179ffdd5976703"
    }
  },
  {
    "ts": null,
    "headline": "Top Research Reports for NVIDIA, Amazon.com & Meta Platforms",
    "summary": "NVIDIA, Amazon.com, and Meta Platforms stand out in Zacks' latest picks, backed by AI growth, AWS strength, and global user gains.",
    "url": "https://finnhub.io/api/news?id=f1946e4e680c5d6241a2ba4f62d08e72ef81b341d5bfe211ca8dad598506ac3a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753217280,
      "headline": "Top Research Reports for NVIDIA, Amazon.com & Meta Platforms",
      "id": 136038079,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "NVIDIA, Amazon.com, and Meta Platforms stand out in Zacks' latest picks, backed by AI growth, AWS strength, and global user gains.",
      "url": "https://finnhub.io/api/news?id=f1946e4e680c5d6241a2ba4f62d08e72ef81b341d5bfe211ca8dad598506ac3a"
    }
  },
  {
    "ts": null,
    "headline": "AbbVie Inc. stock underperforms Tuesday when compared to competitors despite daily gains",
    "summary": "AbbVie Inc. stock underperforms Tuesday when compared to competitors despite daily gains",
    "url": "https://finnhub.io/api/news?id=1aaa943f08369eb5ee7c676d6c207384c82f40a2f5041cf91c6eaa5bf92be233",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753201920,
      "headline": "AbbVie Inc. stock underperforms Tuesday when compared to competitors despite daily gains",
      "id": 136041736,
      "image": "",
      "related": "ABBV",
      "source": "MarketWatch",
      "summary": "AbbVie Inc. stock underperforms Tuesday when compared to competitors despite daily gains",
      "url": "https://finnhub.io/api/news?id=1aaa943f08369eb5ee7c676d6c207384c82f40a2f5041cf91c6eaa5bf92be233"
    }
  },
  {
    "ts": null,
    "headline": "How Will AbbVie's Neuroscience Franchise Perform in Q2 Earnings?",
    "summary": "ABBV's neuroscience sales are projected to jump 15% in Q2, driven by Botox Therapeutic, Vraylar and oral migraine drug gains.",
    "url": "https://finnhub.io/api/news?id=575871e6183099e7c5c71408470fcd8398c2d2ef95611b986cab10f4aa861e38",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753191060,
      "headline": "How Will AbbVie's Neuroscience Franchise Perform in Q2 Earnings?",
      "id": 136033332,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "ABBV's neuroscience sales are projected to jump 15% in Q2, driven by Botox Therapeutic, Vraylar and oral migraine drug gains.",
      "url": "https://finnhub.io/api/news?id=575871e6183099e7c5c71408470fcd8398c2d2ef95611b986cab10f4aa861e38"
    }
  },
  {
    "ts": null,
    "headline": "BOTOX® Cosmetic (onabotulinumtoxinA) Selects This Year's Entrepreneurs for The Confidence Project",
    "summary": "Allergan Aesthetics, an AbbVie company (NYSE: ABBV), today announced the 2025 class of entrepreneurs who will participate in The Confidence Project: Empowering Women Entrepreneurs. This initiative, led by BOTOX® Cosmetic, is aimed at closing the Confidence Gap and accelerating business growth for select entrepreneurs from across the country.",
    "url": "https://finnhub.io/api/news?id=9771884b3536c17a77b99dd1d50402c3a974764fb3024788854835b93c6a5acc",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753185600,
      "headline": "BOTOX® Cosmetic (onabotulinumtoxinA) Selects This Year's Entrepreneurs for The Confidence Project",
      "id": 136031296,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "Allergan Aesthetics, an AbbVie company (NYSE: ABBV), today announced the 2025 class of entrepreneurs who will participate in The Confidence Project: Empowering Women Entrepreneurs. This initiative, led by BOTOX® Cosmetic, is aimed at closing the Confidence Gap and accelerating business growth for select entrepreneurs from across the country.",
      "url": "https://finnhub.io/api/news?id=9771884b3536c17a77b99dd1d50402c3a974764fb3024788854835b93c6a5acc"
    }
  },
  {
    "ts": null,
    "headline": "4 Reasons To Buy AbbVie",
    "summary": "AbbVie's dividends add to its attractiveness at an uncertain time, adding to robust price returns over time. Click here to read an analysis of ABBV stock now.",
    "url": "https://finnhub.io/api/news?id=479b454226aea05801c29b3427f4228697a994200f73aa1d4cd8c9836fefe053",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753183299,
      "headline": "4 Reasons To Buy AbbVie",
      "id": 136032577,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2175801616/image_2175801616.jpg?io=getty-c-w1536",
      "related": "ABBV",
      "source": "SeekingAlpha",
      "summary": "AbbVie's dividends add to its attractiveness at an uncertain time, adding to robust price returns over time. Click here to read an analysis of ABBV stock now.",
      "url": "https://finnhub.io/api/news?id=479b454226aea05801c29b3427f4228697a994200f73aa1d4cd8c9836fefe053"
    }
  },
  {
    "ts": null,
    "headline": "Best Dividend Kings: July 2025",
    "summary": "Discover why 14 Dividend Kings outperform the S&P 500 in 2025.",
    "url": "https://finnhub.io/api/news?id=0abfb9a06bfcdd22331e819cff2f63c95a0a2e603f074263e23c8ab514d9f843",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753176661,
      "headline": "Best Dividend Kings: July 2025",
      "id": 136031024,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2158691690/image_2158691690.jpg?io=getty-c-w1536",
      "related": "ABBV",
      "source": "SeekingAlpha",
      "summary": "Discover why 14 Dividend Kings outperform the S&P 500 in 2025.",
      "url": "https://finnhub.io/api/news?id=0abfb9a06bfcdd22331e819cff2f63c95a0a2e603f074263e23c8ab514d9f843"
    }
  },
  {
    "ts": null,
    "headline": "Polaris Global Equity Composite Q2 2025 Commentary",
    "summary": "The MSCI World Index returned 11.63%, while the Polaris Global Equity Composite gained 8.37%Â (net of fees).",
    "url": "https://finnhub.io/api/news?id=9d6ceb1218e42499545de0ac6edd1a04d15e51afae2e8bc81794f289f7627eba",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753170600,
      "headline": "Polaris Global Equity Composite Q2 2025 Commentary",
      "id": 136030690,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2177686437/image_2177686437.jpg?io=getty-c-w1536",
      "related": "ABBV",
      "source": "SeekingAlpha",
      "summary": "The MSCI World Index returned 11.63%, while the Polaris Global Equity Composite gained 8.37%Â (net of fees).",
      "url": "https://finnhub.io/api/news?id=9d6ceb1218e42499545de0ac6edd1a04d15e51afae2e8bc81794f289f7627eba"
    }
  }
]